About Iotron Medical
Iotron Medical is the world’s first commercial producer of the medical radioisotope Copper‑67 (Cu‑67), used in the development of targeted radiopharmaceutical therapies for cancer.
The Iotron Advantage
Iotron supplies Cu‑67 with exceptional quality, reliability, and technical support.
Why Copper‑67?
Cu‑67 is a versatile therapeutic radioisotope ideal for radioligand therapy. Its properties include:
- Beta emissions effective at destroying cancer cells
- Imageable gamma rays for SPECT scanning (for treatment assessment)
- A 61.8‑hour half‑life suitable for therapy delivery
Contact
To place an order or request information:
- Orders: sales@copper67.com
- General inquiries: enquiries@copper67.com